FdaApplication
ANDA 201616
Identifiers
- fda_app_no: ANDA201616
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA LIMITED |
| application_type | ANDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HYDROCHLOROTHIAZIDE; IRBESARTAN | HYDROCHLOROTHIAZIDE; IRBESARTAN | 12.5MG;300MG | TABLET;ORAL |
| HYDROCHLOROTHIAZIDE; IRBESARTAN | HYDROCHLOROTHIAZIDE; IRBESARTAN | 12.5MG;150MG | TABLET;ORAL |
2 products